Opdivo vs. Yervoy
Are Opdivo and Yervoy the Same Thing?
Opdivo (nivolumab) and Yervoy (ipilimumab) are monoclonal antibodies used to treat different types of cancer.
Opdivo is used to treat patients with unresectable or metastatic melanoma and disease progression following ipilimumab and, if BRAF V600 mutation positive, a BRAF inhibitor; and to treat metastatic squamous non-small cell lung cancer (NSCLC) with progression on or after platinum-based chemotherapy.
Yervoy is used to treat late-stage, metastatic melanoma, a deadly skin cancer. Yervoy is thought to work by allowing the body's immune system to recognize, target, and attack cells in these tumors. Patients with metastatic melanoma are shown to live longer when treated with Yervoy.
Side effects of Opdivo and Yervoy that are similar include diarrhea, mild skin rash or itching, tiredness/fatigue, nausea, and vomiting.
Side effects of Opdivo that are different from Yervoy include cough, upper respiratory tract infection, swelling of extremities, shortness of breath, muscle pain, decreased appetite, constipation, weakness, swelling, fever, abdominal pain, chest pain, joint pain, weight loss, irregular heartbeat, eye inflammation, infusion-related reactions, increased amylase, increased lipase, dizziness, numbness and tingling, skin peeling, skin redness, and psoriasis.
Both Opdivo and Yervoy may interact with other drugs.
What Are Possible Side Effects of Opdivo?
Common side effects of Opdivo include:
- fatigue
- rash
- itching
- cough
- upper respiratory tract infection
- swelling of the extremities
- shortness of breath
- muscle pain
- decreased appetite
- nausea
- vomiting
- constipation
- diarrhea
- weakness
- swelling
- fever
- abdominal pain
- chest pain
- joint pain
- weight loss
- irregular heartbeat
- eye inflammation
- infusion-related reactions
- increased amylase
- increased lipase
- dizziness
- numbness and tingling
- skin peeling
- skin redness and
- psoriasis.
What Are Possible Side Effects of Yervoy?
Common side effects of Yervoy include:
- mild diarrhea,
- mild skin rash or itching,
- tiredness,
- nausea, or
- vomiting.
Tell your doctor if you have serious side effects of Yervoy including:
- severe stomach pain, bloating, constipation, or vomiting; loss of bowel control;
- trouble with daily activities;
- feeling very thirsty or hot, being unable to urinate, heavy sweating, or hot and dry skin;
- urinating less than usual or not at all;
- severe upper stomach pain spreading to your back, nausea and vomiting, fast heart rate;
- fever, cough, trouble breathing; or
- chest pain, feeling short of breath (even with mild exertion), swelling, rapid weight gain.
What Is Opdivo?
Opdivo (nivolumab) is a human monoclonal antibody used to treat patients with unresectable or metastatic melanoma and disease progression following ipilimumab and, if BRAF V600 mutation positive, a BRAF inhibitor; and to treat metastatic squamous non-small cell lung cancer (NSCLC) with progression on or after platinum-based chemotherapy.
What Is Yervoy?
Yervoy (ipilimumab) is a monoclonal antibody used to treat late-stage, metastatic melanoma, a deadly skin cancer. Yervoy is thought to work by allowing the body's immune system to recognize, target, and attack cells in these tumors. Patients with metastatic melanoma are shown to live longer when treated with Yervoy.
What Drugs Interact With Opdivo?
Opdivo may interact with other drugs. Tell your doctor all medications and supplements you use.
How Should Opdivo be Taken?
The recommended dose of Opdivo depends on the condition being treated and whether Opdivo is being administered as a single agent or in combination with another drug.
How Should Yervoy be Taken?
The recommended dose of Yervoy is 10 mg/kg administered intravenously over 90 minutes every 3 weeks for 4 doses followed by 10 mg/kg every 12 weeks for up to 3 years.
All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).
Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.
Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.
The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.
As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.
Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.
If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.
You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.